| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMAM | Exit | AMBRX BIOPHARMA INCcall | $0 | – | -97,700 | -100.0% | -0.20% | – |
| Exit | SOLID BIOSCIENCES INC | $0 | – | -450,403 | -100.0% | -0.21% | – | |
| GRCL | Exit | GRACELL BIOTECHNOLOGIES INCsponsored ads | $0 | – | -579,667 | -100.0% | -0.30% | – |
| TALS | Exit | TALARIS THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -0.51% | – |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -645,899 | -100.0% | -0.59% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -86,302 | -100.0% | -0.68% | – |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -1,022,537 | -100.0% | -0.71% | – |
| ABOS | Exit | ACUMEN PHARMACEUTICALS INC | $0 | – | -1,074,101 | -100.0% | -0.81% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -215,000 | -100.0% | -0.86% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INCcall | $0 | – | -700,000 | -100.0% | -0.87% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -4,737,368 | -100.0% | -0.89% | – |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -615,317 | -100.0% | -0.94% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -6,230,272 | -100.0% | -0.94% | – |
| Exit | APOGEE THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -1.55% | – | |
| RPHM | Exit | RENEO PHARMACEUTICALS INC | $0 | – | -1,167,061 | -100.0% | -1.62% | – |
| INSM | Exit | INSMED INC | $0 | – | -394,872 | -100.0% | -1.82% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -198,500 | -100.0% | -1.83% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -60,500 | -100.0% | -1.86% | – |
| Exit | ARCELLX INC | $0 | – | -287,500 | -100.0% | -1.88% | – | |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -857,000 | -100.0% | -1.90% | – |
| OPTN | Exit | OPTINOSE INC | $0 | – | -8,839,939 | -100.0% | -1.98% | – |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -638,495 | -100.0% | -1.99% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -2.04% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -95,000 | -100.0% | -2.10% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -1,691,768 | -100.0% | -2.11% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -225,000 | -100.0% | -2.14% | – |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -1,091,233 | -100.0% | -2.70% | – |
| IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -290,917 | -100.0% | -2.75% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -894,333 | -100.0% | -2.93% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -500,001 | -100.0% | -3.11% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -600,000 | -100.0% | -3.22% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -2,909,960 | -100.0% | -3.54% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -2,186,934 | -100.0% | -3.64% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -165,200 | -100.0% | -3.65% | – |
| Exit | ZURA BIO LTD | $0 | – | -3,295,000 | -100.0% | -3.96% | – | |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -1,458,070 | -100.0% | -4.41% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -875,044 | -100.0% | -4.46% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -727,426 | -100.0% | -4.72% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -531,211 | -100.0% | -4.93% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -1,755,184 | -100.0% | -5.54% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -3,078,633 | -100.0% | -6.42% | – |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -2,620,545 | -100.0% | -6.69% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTNS, INC CMN | 25 | Q3 2019 | 2.5% |
| IOVANCE BIOTHERAPEUTICS, INC. CMN | 16 | Q1 2021 | 14.3% |
| ZOGENIX INC CMN | 16 | Q4 2019 | 8.8% |
| PTC THERAPEUTICS, INC. CMN | 16 | Q3 2023 | 9.9% |
| EXELIXIS, INC | 16 | Q1 2022 | 7.5% |
| SAGE THERAPEUTICS, INC CMN | 15 | Q3 2021 | 10.8% |
| CYTOKINETICS INC | 15 | Q3 2023 | 5.8% |
| ACADIA PHARMACEUTICALS, INC. | 14 | Q1 2021 | 8.8% |
| ACCELERON PHARMA INC CMN | 14 | Q2 2020 | 8.2% |
| CONNECTURE INC | 13 | Q4 2017 | 25.1% |
View GREAT POINT PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| 89bio, Inc. | February 14, 2023 | 700,000 | 1.4% |
| KalVista Pharmaceuticals, Inc. | February 14, 2023 | 1,055,801 | 3.1% |
| Avalo Therapeutics, Inc. | February 13, 2023 | 974,639 | 7.1% |
| InflaRx N.V.Sold out | February 14, 2022 | 0 | 0.0% |
| ABEONA THERAPEUTICS INC.Sold out | February 16, 2021 | 0 | 0.0% |
| CONSTELLATION PHARMACEUTICALS INC | February 16, 2021 | 1,024,800 | 2.2% |
| GERON CORP | February 16, 2021 | 12,754,228 | 4.0% |
| Millendo Therapeutics, Inc. | February 16, 2021 | 270,000 | 1.4% |
| NextCure, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | February 16, 2021 | 977,647 | 2.4% |
View GREAT POINT PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View GREAT POINT PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.